203 related articles for article (PubMed ID: 28579980)
1. Vaginal
Ñahui Palomino RA; Zicari S; Vanpouille C; Vitali B; Margolis L
Front Microbiol; 2017; 8():906. PubMed ID: 28579980
[No Abstract] [Full Text] [Related]
2. Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.
Tyssen D; Wang YY; Hayward JA; Agius PA; DeLong K; Aldunate M; Ravel J; Moench TR; Cone RA; Tachedjian G
mSphere; 2018 Jul; 3(4):. PubMed ID: 29976641
[TBL] [Abstract][Full Text] [Related]
3. Vaginal pH measured in vivo: lactobacilli determine pH and lactic acid concentration.
O'Hanlon DE; Come RA; Moench TR
BMC Microbiol; 2019 Jan; 19(1):13. PubMed ID: 30642259
[TBL] [Abstract][Full Text] [Related]
4. Vaginal concentrations of lactic acid potently inactivate HIV.
Aldunate M; Tyssen D; Johnson A; Zakir T; Sonza S; Moench T; Cone R; Tachedjian G
J Antimicrob Chemother; 2013 Sep; 68(9):2015-25. PubMed ID: 23657804
[TBL] [Abstract][Full Text] [Related]
5. Lactobacilli inactivate Chlamydia trachomatis through lactic acid but not H2O2.
Gong Z; Luna Y; Yu P; Fan H
PLoS One; 2014; 9(9):e107758. PubMed ID: 25215504
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Trapping of HIV-1 by Human Cervicovaginal Mucus Is Associated with Lactobacillus crispatus-Dominant Microbiota.
Nunn KL; Wang YY; Harit D; Humphrys MS; Ma B; Cone R; Ravel J; Lai SK
mBio; 2015 Oct; 6(5):e01084-15. PubMed ID: 26443453
[TBL] [Abstract][Full Text] [Related]
7. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota.
O'Hanlon DE; Moench TR; Cone RA
PLoS One; 2013; 8(11):e80074. PubMed ID: 24223212
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles from symbiotic vaginal lactobacilli inhibit HIV-1 infection of human tissues.
Ñahui Palomino RA; Vanpouille C; Laghi L; Parolin C; Melikov K; Backlund P; Vitali B; Margolis L
Nat Commun; 2019 Dec; 10(1):5656. PubMed ID: 31827089
[TBL] [Abstract][Full Text] [Related]
9. Vaginal Lactobacilli Reduce
Foschi C; Salvo M; Cevenini R; Parolin C; Vitali B; Marangoni A
Front Cell Infect Microbiol; 2017; 7():502. PubMed ID: 29270390
[TBL] [Abstract][Full Text] [Related]
10. Vaginal microbiome.
Buchta V
Ceska Gynekol; 2018; 83(5):371-379. PubMed ID: 30848142
[TBL] [Abstract][Full Text] [Related]
11. In-vitro effect of vaginal lactobacilli against group B Streptococcus.
Marziali G; Foschi C; Parolin C; Vitali B; Marangoni A
Microb Pathog; 2019 Nov; 136():103692. PubMed ID: 31445119
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles Generated by Gram-Positive Bacteria Protect Human Tissues
Costantini PE; Vanpouille C; Firrincieli A; Cappelletti M; Margolis L; Ñahui Palomino RA
Front Cell Infect Microbiol; 2021; 11():822882. PubMed ID: 35145925
[TBL] [Abstract][Full Text] [Related]
13. Lactobacillus crispatus inhibits the infectivity of Chlamydia trachomatis elementary bodies, in vitro study.
Nardini P; Ñahui Palomino RA; Parolin C; Laghi L; Foschi C; Cevenini R; Vitali B; Marangoni A
Sci Rep; 2016 Jun; 6():29024. PubMed ID: 27354249
[TBL] [Abstract][Full Text] [Related]
14. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis.
Sewankambo N; Gray RH; Wawer MJ; Paxton L; McNaim D; Wabwire-Mangen F; Serwadda D; Li C; Kiwanuka N; Hillier SL; Rabe L; Gaydos CA; Quinn TC; Konde-Lule J
Lancet; 1997 Aug; 350(9077):546-50. PubMed ID: 9284776
[TBL] [Abstract][Full Text] [Related]
15. Why do lactobacilli dominate the human vaginal microbiota?
Witkin SS; Linhares IM
BJOG; 2017 Mar; 124(4):606-611. PubMed ID: 28224747
[TBL] [Abstract][Full Text] [Related]
16. Lactic acid from vaginal microbiota enhances cervicovaginal epithelial barrier integrity by promoting tight junction protein expression.
Delgado-Diaz DJ; Jesaveluk B; Hayward JA; Tyssen D; Alisoltani A; Potgieter M; Bell L; Ross E; Iranzadeh A; Allali I; Dabee S; Barnabas S; Gamieldien H; Blackburn JM; Mulder N; Smith SB; Edwards VL; Burgener AD; Bekker LG; Ravel J; Passmore JS; Masson L; Hearps AC; Tachedjian G
Microbiome; 2022 Aug; 10(1):141. PubMed ID: 36045402
[TBL] [Abstract][Full Text] [Related]
17. Vaginal lactic acid elicits an anti-inflammatory response from human cervicovaginal epithelial cells and inhibits production of pro-inflammatory mediators associated with HIV acquisition.
Hearps AC; Tyssen D; Srbinovski D; Bayigga L; Diaz DJD; Aldunate M; Cone RA; Gugasyan R; Anderson DJ; Tachedjian G
Mucosal Immunol; 2017 Nov; 10(6):1480-1490. PubMed ID: 28401934
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo.
Zabihollahi R; Motevaseli E; Sadat SM; Azizi-Saraji AR; Asaadi-Dalaie S; Modarressi MH
Daru; 2012 Oct; 20(1):53. PubMed ID: 23351891
[TBL] [Abstract][Full Text] [Related]
19. Lactobacillus crispatus inhibits growth of Gardnerella vaginalis and Neisseria gonorrhoeae on a porcine vaginal mucosa model.
Breshears LM; Edwards VL; Ravel J; Peterson ML
BMC Microbiol; 2015 Dec; 15():276. PubMed ID: 26652855
[TBL] [Abstract][Full Text] [Related]
20. Distinct Immune Responses Elicited From Cervicovaginal Epithelial Cells by Lactic Acid and Short Chain Fatty Acids Associated With Optimal and Non-optimal Vaginal Microbiota.
Delgado-Diaz DJ; Tyssen D; Hayward JA; Gugasyan R; Hearps AC; Tachedjian G
Front Cell Infect Microbiol; 2019; 9():446. PubMed ID: 31998660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
